Dear All,
In order to further research in the area of mRNA therapeutics, as well as in
disease areas currently under investigation by Moderna, we are pleased to offer
the opportunity to support research fellowships. These fellowships are intended
to support research in a wide array of disciplines including pharmacometrics.
The application process is intended to be as simple as possible, institutions
apply with a named supervisor and fellow. The fellowship will be awarded for
between 1 and 3 years, and will support salary costs and research expenses. The
program will launch in 2022, and the deadline for applications is December 31st
2021. Successful applications will be informed of the decision by March 31st
2022.
To apply, please download and fill the application form below. Return your
completed application to
[email protected]<mailto:[email protected]>.
Application
https://www.modernatx.com/sites/default/files/u2406/Moderna-GlobalFellowshipApplicationv4.pdf
https://www.modernatx.com/research-fellowship
Regards,
Husain Attarwala, PhD
Director & Head, Clinical Pharmacology and Pharmacometrics | Moderna
mobile (617) 840-0805 | office (617) 803-3425 |
http://modernatx.com/
[signature_2127785708] http://www.modernatx.com/
http://facebook.com/modernatx/
[signature_118176511] https://twitter.com/moderna_tx
[signature_1781966198] http://youtube.com/user/ModernaTx
[signature_1489564253] https://linkedin.com/company/moderna-
P Please consider the environment before printing this email
Confidentiality notice and disclaimer: The information in this message and any
attachments is intended for the exclusive use of the addressee(s), is
confidential and may be privileged or otherwise protected from disclosure. Any
review, retransmission, dissemination or other use of, or taking of any action
in reliance upon, of any such information by persons or entities other than the
intended addressee(s) is prohibited. If you have received this message in error
and are not the intended addressee, please notify the sender immediately and
delete this message and any attachments from your system without reading or
disclosing them. If you are not the intended addressee, be advised that any use
of the information in this message and any attachment is prohibited and may be
unlawful, and you must not copy this message or attachment or disclose the
contents to any other person.